Procyrion's micro-heart pump moving forward

Today's Medical Developments
October 13, 2015

Articles

Experiments boost Procyrion's micro-heart pump presented at scientific conference; Circulatory pump earns spot in TCT Interventional Innovation "Shark Tank” competition; earned a share of the 2015 Universal Biotech Innovation Prize.

Read More
The Aortix™ device is currently in the research and development phase and is not available for sale in any country.
Caution: Investigational Device. Limited by Federal Law to Investigational Use.

Links

HomeClinical TrialsOverviewTeamNewsCareersReferencesDisclaimer & Terms of UseContact

LATEST NEWS

March 2024
Fierce Biotech
Procyrion Recognized in Fierce Medtech's Fierce15 of 2023
February 2024
Press Release
Procyrion Closes $57.7 Million in Series E Financing
November 2023
Press Release
Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix™ Percutaneous Mechanical Circulatory Support Technology

ABOUT US

Procyrion is a team of experienced life science entrepreneurs, engineers, cardiologists, and heart failure specialists.

Our dedicated team is working to address the unmet clinical needs of heart failure patients through the development of a safe and innovative percutaneous mechanical circulatory support (pMCS) device.

Copyright © 2021 Procyrion, Inc.
Disclaimer & Terms of Use
Aortix™ is for investigational use only and is not for sale in the United States.